Crain's New York Business interviews Michael P. Ast, MD, Chief Medical Innovation Officer and Director of Ambulatory Surgery Center Strategy at HSS about how robotics and AI are transforming joint replacement. 

Personalized medicine is the wave of the future, a time when treatment plans will be tailored to an individual patient based on their genetic makeup, environment and lifestyle.

The burgeoning field is particularly impactful in areas like cancer treatment, where genetic testing can play a role.

HSS is developing ways to personalize orthopedic surgery.

The institution is a leader in the field of robotics, and now it’s looking at combining robotics with artificial intelligence to deliver personalized surgical plans.

Robotic surgery has been around for decades, but the field is ever-advancing as tools become smaller and more sophisticated, providing greater precision, reduced recovery time and lower risk of complications.

Dr. Ast has performed all of his knee replacement surgeries with robotic tools for years. He is always looking for new technologies to achieve better outcomes for his patients, and, he said, AI will be a driver.

Read the full article at crainsnewyork.com.